LIV-1205 (CBA-1205) 是 CHO 表达的人源化抗体，靶向 DLK1。LIV-1205 (CBA-1205) 带有 huIgG1 型重链和 huκ 型轻链，其预测的分子量 (MW) 为 150 kDa。LIV-1205 (CBA-1205) 的同型对照可参考 Human IgG1 kappa, Isotype Control。

For Powder, reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.

本产品仅用作科学研究！

Anti-DLK1 Reference Antibody (LIV-1205) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

The purity of Anti-DLK1 Reference Antibody (LIV-1205) is more than 95%, determined by SEC-HPLC.

Immobilized human DLK1.1 His at 2 ug/mL can bind Anti-DLK1 Reference Antibody (LIV-1205), EC50=0.01281 ug/mL.

Human DLK1 HEK293 cells were stained with Anti-DLK1 Reference Antibody (LIV-1205) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.1334 ug/mL.

-80°C for 2 years under sterile conditions；-20°C for 1 year under sterile conditions；Avoid repeated freeze-thaw cycles.